New drug to treat one of the deadliest cancers is 'the real deal,' oncologist says - KSL.com

1 sources1 storiesFirst seen 8/12/2026Score31Mixed Progress

Single Source

Bigness

Coverage

Recency

Engagement

Velocity

Confidence

Clipability

Polarization

Claims

Contradictions

Breakthrough

Sentiment Mix

Positive0%

Neutral100%

Negative0%

Geography

North America

Expert Signals

Politics - Google News US Headlines

source • 1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

New drug to treat one of the deadliest cancers is 'the real deal,' oncologist says - KSL.com.

Supported by 1 story

New drug to treat one of the deadliest cancers is 'the real deal,' oncologist says KSL.comAcquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer NaturePancreatic Cancer Specialists Getting a Jump on Daraxonrasib MedscapePatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer' Chicago Tribune'Game changer' drug gives new hope in pancreatic cancer fight USA Today

Supported by 1 story